We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MTNB Matinas Biopharma Holdings Inc

-0.0007 (-0.32%)
Pre Market
Last Updated: 06:06:39
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Matinas Biopharma Holdings Inc MTNB AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0007 -0.32% 0.22 06:06:39
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
11/20/202307:30EDGAR2Form 8-K - Current report
11/09/202317:25EDGAR2Form 8-K - Current report
11/08/202316:06EDGAR2Form 8-K - Current report
11/08/202316:05GLOBEMatinas BioPharma Reports Third Quarter 2023 Financial..
11/08/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:30GLOBEMatinas BioPharma Announces Positive in vivo Efficacy..
11/03/202316:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202317:20EDGAR2Form 8-K - Current report
11/01/202307:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
10/11/202310:25APSBiotech Catches Massive Premarket Bid
10/11/202307:30GLOBEPatient with Candida krusei Infection in Matinas BioPharma’s..
9/28/202307:00GLOBEMatinas BioPharma to Present at Two Investment Conferences..
9/27/202307:00GLOBEMatinas BioPharma to Feature MAT2203 in a Pipeline..
9/22/202317:25EDGAR2Form 8-K - Current report
9/22/202317:25GLOBEMatinas BioPharma Announces Notification of NYSE American..
9/21/202309:35GLOBEDawson James Securities Announces October Date for 8th..
9/20/202307:30EDGAR2Form 8-K - Current report
9/19/202317:25EDGAR2Form DEF 14A - Other definitive proxy statements
9/08/202317:15EDGAR2Form PRE 14A - Other preliminary proxy statements
9/06/202307:00GLOBEMatinas BioPharma to Participate in the H.C. Wainwright..
8/22/202307:30GLOBEMatinas BioPharma Announces Publication of Results from the..
8/09/202316:06EDGAR2Form 8-K - Current report
8/09/202316:05GLOBEMatinas BioPharma Reports Second Quarter 2023 Financial..
8/09/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202307:00GLOBEMatinas BioPharma to Participate in the BTIG Virtual..
7/26/202308:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
7/07/202317:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/11/202307:30GLOBEMatinas BioPharma to Present at the JMP Securities Life..
5/10/202316:05GLOBEMatinas BioPharma Reports First Quarter 2023 Financial..
5/03/202307:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss..
4/18/202308:00GLOBECompassionate Use Patient Treated with Matinas BioPharma’s..
3/15/202316:05GLOBEMatinas BioPharma Reports 2022 Financial Results and..
3/08/202307:00GLOBEMatinas BioPharma to Webcast Conference Call to Discuss 2022..
3/02/202307:00GLOBEMatinas BioPharma Announces that MAT2203 Will Be Featured in..
1/30/202316:01GLOBEMatinas BioPharma Provides Business Update and 2023..
1/23/202307:00GLOBEMatinas BioPharma to Provide Corporate Update and 2023..
1/12/202307:00GLOBEMatinas BioPharma Announces Collaboration with National..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |